A carregar...
Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
OBJECTIVE: To evaluate the budget impact and the direct costs of the introduction of subcutaneous belimumab (SC) into the Spanish National Health Service (NHS) for patients with systemic lupus erythematosus (SLE) in Spain. METHODS: This study was conducted from the Spanish NHS perspective with a tim...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901000/ https://ncbi.nlm.nih.gov/pubmed/31824182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S218464 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|